LEVEL 4 C08DA01

Δραστικές

VERAPAMIL

Φάρμακα

  • DRUGBANK - Verapamil
  • indication:

    For the treatment of hypertension, angina, and cluster headache prophylaxis.

  • pharmacology:

  • mechanism:

    Verapamil inhibits voltage-dependent calcium channels. Specifically, its effect on L-type calcium channels in the heart causes a reduction in ionotropy and chronotropy, thuis reducing heart rate and blood pressure. Verapamil's mechanism of effect in cluster headache is thought to be linked to its calcium-channel blocker effect, but which channel subtypes are involved is presently not known.

  • toxicity:

    LD<sub>50</sub>=8 mg/kg (i.v. in mice)

  • absorprion:

    90%

  • halflife:

    2.8-7.4 hours

  • roouteelimination:

    Approximately 70% of an administered dose is excreted as metabolites in the urine and 16% or more in the feces within 5 days. About 3% to 4% is excreted in the urine as unchanged drug.

  • volumedistribution:

  • clearance: